Cargando…
A DNA Aptamer Targeting Galectin-1 as a Novel Immunotherapeutic Strategy for Lung Cancer
Galectin-1 (Gal-1) is a pleiotropic homodimeric β-galactoside-binding protein with a single carbohydrate recognition domain. It has been implicated in several biological processes that are important during tumor progression. Several lines of evidence have indicated that Gal-1 is involved in cancer i...
Autores principales: | Tsai, Yao-Tsung, Liang, Chen-Hsien, Yu, Jin-Hsuan, Huang, Kuan-Chih, Tung, Chia-Hao, Wu, Jia-En, Wu, Yi-Ying, Chang, Chih-Hsien, Hong, Tse-Ming, Chen, Yuh-Ling |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6889073/ https://www.ncbi.nlm.nih.gov/pubmed/31778957 http://dx.doi.org/10.1016/j.omtn.2019.10.029 |
Ejemplares similares
-
DNA methylation maintains the CLDN1-EPHB6-SLUG axis to enhance chemotherapeutic efficacy and inhibit lung cancer progression
por: Wu, Jia-En, et al.
Publicado: (2020) -
A novel DNA aptamer targeting lung cancer stem cells exerts a therapeutic effect by binding and neutralizing Annexin A2
por: Wu, Yi-Ying, et al.
Publicado: (2022) -
Serum Galectin-3 Level Is Positively Associated with Endothelial Dysfunction in Patients with Chronic Kidney Disease Stage 3 to 5
por: Hsu, Bang-Gee, et al.
Publicado: (2021) -
The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment
por: Chen, Tseng-Cheng, et al.
Publicado: (2017) -
Utility of High-Sensitivity Modified Glasgow Prognostic Score in Cancer Prognosis: A Systemic Review and Meta-Analysis
por: Wu, Tsung-Hsien, et al.
Publicado: (2023)